People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Investment Vehicle, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FCA Venture Partners VII QP, LP | — | Investment Vehicle | Series C | $60.3M | $847.5M | 2021 |
| FCA Health Innovations II QP, LP | — | Healthtech | Series C | $55.1M | $1.3B | 2020 |
| FCA Venture Partners VI, LP | — | Investment Vehicle | Series A | $15.0M | $227.0M | 2016 |
| FCA Venture Partners VII, LP | — | Investment Vehicle | Series A | $8.8M | $98.2M | 2021 |
| FCA Health Innovations II, LP | — | Healthtech | Series A | $8.5M | $167.8M | 2020 |
| Dioko Health Ventures I, LP | — | Investment Vehicle | Series A | $7.0M | $105.9M | 2016 |
| Resolute Venture Partners I, LP | — | Investment Vehicle | Seed | $3.6M | $66.9M | 2016 |
Nancy S. Allen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nancy S. Allen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew A> King | 6 | 14 |
| JOHN R. BURCH, JR. | 4 | 7 |
| James A Patton | 4 | 5 |
| Andrew J Bouldin | 4 | 4 |
| Whitney L Haley | 4 | 4 |
| Thomas K. Hearn III | 3 | 4 |
| Whitney H Kalb | 2 | 2 |
| Charles (Todd) W Johnson | 2 | 2 |
| Whitney L Kalb | 2 | 2 |
| Charles W Johnson | 1 | 6 |
| Andrew S. Bouldin | 1 | 1 |
| Jay S Zeidman | 1 | 1 |
| John R. Burch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.